{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T15:01:05Z","timestamp":1775919665512,"version":"3.50.1"},"reference-count":104,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T00:00:00Z","timestamp":1532649600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hemophilia is associated with a high financial burden on individuals, healthcare systems, and society. The development of inhibitors significantly increases the socioeconomic burden of the diseases. This study aimed to review and describe the burden of hemophilia with inhibitors, providing a reference scenario to assess the impact of new products in the real word. Two systematic literature reviews were performed to collect data on (i) health economics and (ii) health\u2010related quality of life evidences in hemophilic patients with inhibitors. The costs associated with patients with hemophilia and inhibitors are more than 3 times greater than the costs incurred in those without inhibitors, with an annual cost per patient that can be higher than \u20ac1\u00a0000\u00a0000. The costs of bypassing agents account for the large majority of the total healthcare direct costs for hemophilia treatment. The quality of life is more compromised in patients with hemophilia and inhibitors compared to those without inhibitors, in particular the physical domains, whereas mental domains were comparable to that of the general population. The development of an inhibitor has a high impact on costs and quality of life. New treatments have the potential to change positively the management and socioeconomic burden of hemophilia with inhibitors.<\/jats:p>","DOI":"10.1111\/ejh.13108","type":"journal-article","created":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T14:59:54Z","timestamp":1528729194000},"page":"435-456","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["The socioeconomic burden of patients affected by hemophilia with inhibitors"],"prefix":"10.1111","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6248-2760","authenticated-orcid":false,"given":"Lucia S.","family":"D'Angiolella","sequence":"first","affiliation":[{"name":"Research Centre on Public Health (CESP) University of Milano Bicocca  Monza Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo A.","family":"Cortesi","sequence":"additional","affiliation":[{"name":"Research Centre on Public Health (CESP) University of Milano Bicocca  Monza Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angiola","family":"Rocino","sequence":"additional","affiliation":[{"name":"Hemophilia &amp; Thrombosis Centre San Giovanni Bosco Hospital  Naples Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Coppola","sequence":"additional","affiliation":[{"name":"Regional Reference Center for Inherited Bleeding Disorders University Hospital of Parma  Parma Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamisa J.","family":"Hassan","sequence":"additional","affiliation":[{"name":"Department of Oncology and Molecular Medicine Istituto Superiore di Sanit\u00e0  Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adele","family":"Giampaolo","sequence":"additional","affiliation":[{"name":"Department of Oncology and Molecular Medicine Istituto Superiore di Sanit\u00e0  Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi P.","family":"Solimeno","sequence":"additional","affiliation":[{"name":"Division of Orthopaedic Surgery and Traumatology Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico  Milan Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Lafranconi","sequence":"additional","affiliation":[{"name":"Research Centre on Public Health (CESP) University of Milano Bicocca  Monza Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariangela","family":"Micale","sequence":"additional","affiliation":[{"name":"Research Centre on Public Health (CESP) University of Milano Bicocca  Monza Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sveva","family":"Mangano","sequence":"additional","affiliation":[{"name":"Research Centre on Public Health (CESP) University of Milano Bicocca  Monza Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Crotti","sequence":"additional","affiliation":[{"name":"Research Centre on Public Health (CESP) University of Milano Bicocca  Monza Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Pagliarin","sequence":"additional","affiliation":[{"name":"Research Centre on Public Health (CESP) University of Milano Bicocca  Monza Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Cesana","sequence":"additional","affiliation":[{"name":"Research Centre on Public Health (CESP) University of Milano Bicocca  Monza Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo G.","family":"Mantovani","sequence":"additional","affiliation":[{"name":"Research Centre on Public Health (CESP) University of Milano Bicocca  Monza Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,7,27]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1615621"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12317"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2013.10.016"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2009.02127.x"},{"key":"e_1_2_6_6_1","unstructured":"ISS.17\/14 \u2010 Registro Nazionale Coagulopatie Congenite. Rapporto2015.http:\/\/www.iss.it\/publ\/index.php?lang=1&id=3060&tipo=5.Accessed February 12 2018."},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm6030034"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1326786"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0000000000000647"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12404"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-09-457036"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH14-10-0826"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1356715"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12229"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH16-02-0116"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-03-0941"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2006.01204.x"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12672"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm6040046"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12028"},{"issue":"1","key":"e_1_2_6_21_1","first-page":"s319","article-title":"Key issues in inhibitor management in patients with haemophilia","volume":"12","author":"Gomez K","year":"2014","journal-title":"Blood Transfus"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02663.x"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104435"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12246"},{"key":"e_1_2_6_25_1","doi-asserted-by":"crossref","unstructured":"MahlanguJOJ CallaghanMU ShimaM et\u00a0al.Bleeding Events and Safety Outcomes in Patients with Hemophilia a with Inhibitors: A Prospective Multicenter Non\u2010Interventional Study.Blood.2016;128:3800.","DOI":"10.1182\/blood.V128.22.3800.3800"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2007.01518.x"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-01-195313"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12080"},{"key":"e_1_2_6_29_1","first-page":"478","article-title":"The role of recombinant activated factor VII in the haematological management of elective orthopaedic surgery in haemophilia A patients with inhibitors","volume":"15","author":"Castaman G","year":"2017","journal-title":"Blood Transfus"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2008.01952.x"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07613.x"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12730"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12028"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24543"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15084"},{"key":"e_1_2_6_36_1","unstructured":"CHMP Summary of positive opinion for Hemlibra \u2013 EMA;2018.http:\/\/www.ema.europa.eu."},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1703068"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12864"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1616569"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-015-1134-3"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2004.00950.x"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2017.04.017"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2008.01862.x"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12681"},{"key":"e_1_2_6_45_1","first-page":"669","article-title":"Cost\u2010effectiveness analysis of biogeneric recombinant activated factor VII (AryoSeven\u2122) and activated prothrombin complex concentrates (FEIBA\u2122) to treat hemophilia a patients with inhibitors in Iran","volume":"15","author":"Golestani M","year":"2016","journal-title":"Iranian J Pharm Res"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12780"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2013.11.002"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.3111\/200508046054"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.3111\/200205051064"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2011.02713.x"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1999.00368.x"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2011.02677.x"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2013.54.2.358"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12456"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1334929"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12621"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.5.1698.h8001698_1698_1702"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1999.00321.x"},{"key":"e_1_2_6_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08263.x"},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12158"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12178"},{"key":"e_1_2_6_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2009.02179.x"},{"key":"e_1_2_6_63_1","first-page":"229","article-title":"Different treatment strategies for haemophilia a with Low inhibitor","volume":"27","author":"Mirbehbahani N","year":"2011","journal-title":"Pak J Med Sci"},{"key":"e_1_2_6_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2007.01474.x"},{"key":"e_1_2_6_65_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1615388"},{"key":"e_1_2_6_66_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01128.x"},{"key":"e_1_2_6_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12371"},{"key":"e_1_2_6_68_1","first-page":"85","article-title":"Cost components of treatment protocols of haemophilia patients with inhibitors using bypassing agents in Iran","volume":"12","author":"Golestani M","year":"2016","journal-title":"Iran J Pharm Sci"},{"key":"e_1_2_6_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2011.02589.x"},{"key":"e_1_2_6_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.05.005"},{"key":"e_1_2_6_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12390"},{"key":"e_1_2_6_72_1","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2011.647176"},{"key":"e_1_2_6_73_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12019"},{"key":"e_1_2_6_74_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2001.00502.x"},{"key":"e_1_2_6_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2008.01654.x"},{"key":"e_1_2_6_76_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24856"},{"key":"e_1_2_6_77_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-017-0643-7"},{"key":"e_1_2_6_78_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2009.02032.x"},{"key":"e_1_2_6_79_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12454"},{"key":"e_1_2_6_80_1","unstructured":"AIFA.Elenco dei medicinali di fascia C e H;2018.http:\/\/www.agenziafarmaco.gov.it. Accessed March 2 2018."},{"key":"e_1_2_6_81_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2012.02847.x"},{"key":"e_1_2_6_82_1","unstructured":"AbbonizioFGA ArcieriR HassanHJ Associazione Italiana Centri Emofilia (AICE). Rapporto2014. Accessed April 1 2018."},{"key":"e_1_2_6_83_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1648230"},{"key":"e_1_2_6_84_1","doi-asserted-by":"publisher","DOI":"10.5045\/br.2015.50.3.173"},{"key":"e_1_2_6_85_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2003.00849.x"},{"key":"e_1_2_6_86_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2006.01370.x"},{"key":"e_1_2_6_87_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-007-9181-4"},{"key":"e_1_2_6_88_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2008.01696.x"},{"key":"e_1_2_6_89_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2008.01915.x"},{"key":"e_1_2_6_90_1","doi-asserted-by":"publisher","DOI":"10.2147\/CEOR.S25909"},{"key":"e_1_2_6_91_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2005.01098.x"},{"key":"e_1_2_6_92_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X80224"},{"key":"e_1_2_6_93_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2007.01522.x"},{"key":"e_1_2_6_94_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH07-11-0698"},{"key":"e_1_2_6_95_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007990802633863"},{"key":"e_1_2_6_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2012.02.005"},{"key":"e_1_2_6_97_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2011.02623.x"},{"key":"e_1_2_6_98_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12199"},{"key":"e_1_2_6_99_1","unstructured":"The EuroQoL Group.EQ\u20105D\u20105L. User Guide. Basic information on how to use the EQ\u20105D\u20105L instrument.http:\/\/euroqol.org\/. Accessed February 26 2018."},{"key":"e_1_2_6_100_1","doi-asserted-by":"publisher","DOI":"10.1177\/2050312116671725"},{"key":"e_1_2_6_101_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-16899"},{"key":"e_1_2_6_102_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-198004000-00010"},{"key":"e_1_2_6_103_1","unstructured":"WareJ.Usee's manual for the SF\u201012v2 health survey (with a supplement documenting SF\u201012 health survey).http:\/\/www.worldcat.org\/. Accessed February 26 2018."},{"key":"e_1_2_6_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2004.04.056"},{"key":"e_1_2_6_105_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2009.02038.x"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fejh.13108","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ejh.13108","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T13:21:48Z","timestamp":1728480108000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ejh.13108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,27]]},"references-count":104,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.1111\/ejh.13108"],"URL":"https:\/\/doi.org\/10.1111\/ejh.13108","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,27]]},"assertion":[{"value":"2018-06-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}